Asthma meds have become shockingly unaffordable − but relief may be on the way

An inhaler that costs nearly $300 in the US goes for just $9 in Germany. What gives?

Ana Santos Rutschman, Professor of Law, Villanova School of Law • conversation
March 8, 2024 • ~7 min

Medicare starts a long road to cutting prices for drugs, starting with 10 costing it $50.5 billion annually – a health policy analyst explains why negotiations are promising but will take years

The drug pricing reform may drastically lower prices for some of the most critical life-saving drugs in the long run. But numerous obstacles stand in the way.

Simon F. Haeder, Associate Professor of Public Health, Texas A&M University • conversation
Aug. 30, 2023 • ~11 min

Blame capitalism? Why hundreds of decades-old yet vital drugs are nearly impossible to find

The shortages, which have been going on for years, have typically affected only low-cost generics rather than profitable brand-name drugs.

Geoffrey Joyce, Director of Health Policy, USC Schaeffer Center, and Associate Professor, University of Southern California • conversation
July 20, 2023 • ~9 min

Ending the pandemic will take global access to COVID-19 treatment and vaccines – which means putting ethics before profits

The high cost of pharmaceuticals often means only the richest patients get lifesaving medicines. As coronavirus drugs emerge, it will require hard, creative work to ensure they're available to all.

Nicole Hassoun, Associate Professor of Philosophy, Binghamton University, State University of New York • conversation
July 16, 2020 • ~9 min

/

1